Overview
Rong Du practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Anti-NMDA Receptor Encephalitis, and Trabeculectomy.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rong Du
Is Rong Du a top-rated expert for Trabeculectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Rong Du is classified as an Experienced expert for Trabeculectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rong Du participate in research or clinical trials?
Yes. Rong Du has published 12 articles and abstracts on conditions like Trabeculectomy. You can view a list of Rong Du's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anti-NMDA Receptor Encephalitis
- GlaucomaDu isExperienced. Learn about Glaucoma.
- Hashimoto ThyroiditisDu isExperienced. Learn about Hashimoto Thyroiditis.
- Ocular Hypertension (OHT)
- Pigment-Dispersion Syndrome
- TrabeculectomyDu isExperienced. Learn about Trabeculectomy.